47 studies found for: systemic lupus erythematosus AND mycophenolic acid

Transcription

1 Recherche in auf der Webseite zuletzt am studies found for: systemic lupus erythematosus AND mycophenolic acid Rank Status Study 1 Terminate d Myfortic Versus Azathioprine in Systemic Lupus Erythematosus Interventions: Drug: switch to Myfortic; Drug: contin 2 Completed Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) Conditions: Systemic Lupus Erythematosus; Athero Interventions: Drug: Mycophenolate mofetil; Drug: s 3 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Conditions: Systemic Lupus Erythematosus; SLE Interventions: Drug: Mycophenolate Mofetil; Drug: H oquine; Drug: Prednisone 4 Recruiting Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus, Lupus N Interventions: Drug: Oral prednisolone; Drug: Rituxim mofetil; Drug: Methyl prednisolone 5 Completed Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Interventions: Drug: laquinimod; Drug: Mycophenola roids; Drug: Placebo 6 Active, not 7 Terminate d Has Results Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestations Interventions: Drug: Azathioprine; Drug: Enteric- Coated Mycophenolate Sodium Efficacy and Safety Study of Abatacept to Treat Lupus Interventions: Drug: Corticosteroids (prednisone or prednisolone); Drug: Abatacept; Drug MMF) 8 Completed Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis Conditions: Systemic Lupus Erythematosus; Arthri Interventions: Drug: mycophenolate mofetil; Other: p late mofetil 9 Withdrawn Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell

2 Transplant (LIST) Condition: Interventions: Systemic Lupus Erythematosus Procedure: Leukapheresis; Procedure: immunosuppressive therapy conditionin Autologous CD34+HPC transplantation (HSCT); Procedure: Plasmapheresis; thymocyte globulin; Drug: Methylpred timulating factor (G- CSF); Drug: Corticosteroids; Drug: M athioprine; Drug: Intravenous immunog Drug: Rituximab; Drug: Leflunomide 10 Active, not A Study to Evaluate Ocrelizumab in Patients With Due to Systemic Lupus Erythematosus (BELONG) Conditions: Lupus ; Systemic Lupus Eryth Interventions: Drug: corticosteroids; Drug: cyclophos te mofetil; Drug: ocrelizumab; Drug: 11 Recruiting ACTHar in the Treatment of Lupus Interventions: Drug: CellCept; Drug: Acthar gel 12 Completed Has Results A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Condition: Interventions: Lupus Drug: Rituximab; Drug: Placebo; Dru : Methylprednisolone; Drug: Diphenhy Drug: Prednisone 13 Recruiting Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) Conditions: Lupus Erythematosus; Graft-versus-ho Interventions: Drug: Cyclophosphamide; Drug: Sodiu mercapto ethane sulphonate; Drug: Flu : Tacrolimus; Drug: Mofetil; Drug: Ra 14 Terminate d Has Results Etanercept for the Treatment of Lupus Interventions: Drug: Etanercept; Drug: Lupus Treatm Standard of Care; Drug: Placebo 15 Completed Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76 Condition: Interventions: Systemic Lupus Erythematosus Drug: Belimumab 1 mg/kg; Drug: Beli Placebo

3 16 Active, not Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis Condition: Systemic Sclerosis Intervention: Drug: Belimumab 17 Completed Exploratory Study of Changes in Disease Activity and Biomarkers With ABR in Patients With Mild Active Systemic Lupus Erythematosus (SLE) Intervention: Drug: paquinimod (ABR ) 18 Recruiting A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus Interventions: Drug: Ustekinumab IV; Drug: Placebo Drug: Ustekinumab SC; Other: Concom 19 Active, not 20 Active, not Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant Conditions: Transplantation Infection; Cytomegalo Interventions: Drug: Everolimus; Drug: Very Low Ta us; Drug: Steroids; Drug: Thymoglob late Health-related Quality of Life Measure in Pediatric Lupus Conditions: Systemic Lupus Erythematosus; Qualit Intervention: 21 Unknown Allogeneic Blood Stem Cell Transplantation for Patients With Life- Threatening Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Intervention: Procedure: Hematopoietic Cell Transp 22 Unknown Cyclophosphamide in Lupus Intervention: 23 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Interventions: Biological: Placebo plus standard thera Belimumab 10 mg/kg plus standard therapy; Drug: Standard therapy 24 Completed Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Flare

4 Interventions: Drug: Mycophenolate sodium; Drug: Prednisone; D rednisolone 25 Withdrawn Clinical Trial Treatment in Lupus Interventions: Drug: cyclosporine +mycophenolic aci enolic Acid + prednison 26 Completed Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Intervention: Drug: Mycophenolate mofetil 27 Terminated The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Interventions: Drug: mycophenolate sodium; Drug: 28 Completed A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus. Interventions: Drug: Mycophenolate mofetil (MMF); Azathioprine; Drug: Placebo to Azat henolate mofetil; Drug: Corticosteroid 29 Completed Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Interventions: Drug: tacrolimus; Drug: mycophenola 30 Terminated A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus. Interventions: Drug: Mycophenolate Mofetil; Drug: oprine; Drug: Cyclophosphamide 31 Completed Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus. Interventions: Drug: Mycophenolate mofetil; Drug: 32 Recruiting Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Interventions: Drug: Tacrolimus; Drug: Mycopheno 33 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil

5 (MMF) for Induction of Remission in Lupus Intervention: Drug: Tacrolimus vs. Mycophenolate m Induction Therapy in Lupus 34 Recruiting Efficacy and Safety Study of Abatacept to Treat Lupus Interventions: Biological: BMS ; Drug: Mycophenolate mofet cal: Placebo matching with BMS Terminated A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Interventions: Drug: Mycophenolate mofetil (MMF); enance Phase; Drug: Cyclophospham nisone 36 Recruiting The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear Intervention: Drug: mycophenolic acid 37 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Intervention: 38 Terminated The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Interventions: Drug: MMF; Drug: Atacicept plus M 39 Completed A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Conditions: Lupus ; Glomerulonephritis, Interventions: Drug: prednisolone and mycophenolate e and tacrolimus 40 Completed Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Intervention: Drug: low dose combination of MMF a 41 Completed Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus (III/IV/V) Intervention: Drug: Multitherapy

6 42 Terminated BIIB023 Proof-of-Concept Study in Participants With Lupus Interventions: Biological: BIIB023; Biological: Plac te Mofetil 43 Terminated Atacicept in Lupus Patients Taking Stable Regimen of Mycophenolate Mofetil Intervention: Drug: Atacicept 44 Completed Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Interventions: Drug: Multi-target therapy; Drug: Az 45 Recruiting A Study to Evaluate the Safety and Efficacy of Obinutuzumab, an Antibody Targeting Certain Types of Immune Cells, in Participants With Lupus (LN) Interventions: Drug: Mycophenolate Mofetil; Drug: acebo 46 Completed Assess the Efficacy and Safety of Multi-target Therapy in Lupus Interventions: Drug: Tacrolimus+Mycophenolate mo amide 47 Terminated BIIB023 Long-Term Extension Study in Subjects With Lupus Interventions: Biological: BIIB023; Drug: Backgrou